Back to DRIEHAUS CAPITAL MANAGEMENT LLC DRIEHAUS CAPITAL MANAGEMENT LLC

KNSAKNSA
9 quarters

Position history for DRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC's holdings in KINIKSA PHARMACEUTICALS INTE

Yes. Driehaus Capital Management holds 718,199 shares of KNSA (Kiniksa Pharmaceuticals Inte), worth $45.9M, as of its Q2 2026 13F filing. It increased the position by 106,801 shares (+17.5%) from Q1 2026. Driehaus Capital Management has held KNSA in every 13F on record since Q2 2024, 9 quarterly filings. KNSA is 0.3% of Driehaus Capital Management's reported 13F portfolio.

Current Value

$45.9M

Current Shares

718,199

Total Value Change

+$34.4M

Total Shares Change

+102,363

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
718,199
+17.5%
$45.9M0.3%$63.95
41
2026-Q1
Decreased
611,398
-3.4%
$29.4M0.2%$48.15
0
2025-Q4
Decreased
632,827
-3.3%
$26.1M0.2%$41.25
0
2025-Q3
Increased
654,585
+1.0%
$25.4M0.2%$38.83
35
2025-Q2
Increased
647,980
+6.0%
$17.9M0.1%$27.67
36
2025-Q1
Decreased
611,278
-0.4%
$13.6M0.1%$22.21
0
2024-Q4
Decreased
613,550
-16.1%
$12.1M0.1%$19.78
0
2024-Q3
Increased
730,943
+18.7%
$18.3M0.2%$24.99
40
2024-Q2
New
615,836
-
$11.5M0.1%$18.67
46

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used